Menglu Fu
Impact in
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
-
- Diabetes Treatment and Management
Papers in
-
- Hormonal Regulation and Hypertension 5
- Diet, Metabolism, and Disease 3
-
- Eicosanoids and Hypertension Pharmacology 7
- Co-authors
- Ling Tu (15 shared papers)Xizhen Xu (14 shared papers)Ruolan Dong (14 shared papers)Jinlan Luo (10 shared papers)Yan Yang (11 shared papers)Zhihui Chen (9 shared papers)Shuiqing Hu (8 shared papers)Wenhua Li (4 shared papers)
In The Last Decade
Menglu Fu
16 papers receiving 334 citations
Peers
Comparison fields: 5 of 85
- Biochemistry 62
- Endocrinology, Diabetes and Metabolism 64
- Nephrology 20
- Biological Psychiatry 7
- Geriatrics and Gerontology 10
Countries citing papers authored by Menglu Fu
This map shows the geographic impact of Menglu Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Menglu Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Menglu Fu more than expected).
Fields of papers citing papers by Menglu Fu
This network shows the impact of papers produced by Menglu Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Menglu Fu. The network helps show where Menglu Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Menglu Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 69 | |
| 2 | 2020 | 64 | |
| 3 | 2020 | 60 | |
| 4 | 2019 | 25 | |
| 5 | 2017 | 19 | |
| 6 | 2021 | 17 | |
| 7 | 2020 | 17 | |
| 8 | 2018 | 16 | |
| 9 | 2019 | 12 | |
| 10 | 2024 | 10 | |
| 11 | 2017 | 10 | |
| 12 | 2020 | 9 | |
| 13 | 2022 | 5 | |
| 14 | 2021 | 4 | |
| 15 | 2019 | 3 | |
| 16 | 2023 | 2 |
About Menglu Fu
Menglu Fu is a scholar working on Endocrinology, Diabetes and Metabolism, Biochemistry, Molecular Biology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine, having authored 16 papers that have together received 342 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (7 papers), Hormonal Regulation and Hypertension (5 papers), Diet, Metabolism, and Disease (3 papers), Alcohol Consumption and Health Effects (3 papers), Microbial Metabolites in Food Biotechnology (1 paper), Long-Term Effects of COVID-19 (1 paper), Metabolism, Diabetes, and Cancer (1 paper) and Protein Tyrosine Phosphatases (1 paper). The work is most often cited by research in Biochemistry (62 citations), Endocrinology, Diabetes and Metabolism (64 citations), Nephrology (20 citations), Biological Psychiatry (7 citations) and Geriatrics and Gerontology (10 citations). Menglu Fu has collaborated with scholars based in China and Poland. Frequent co-authors include Ling Tu, Xizhen Xu, Ruolan Dong, Jinlan Luo, Yan Yang, Zhihui Chen, Shuiqing Hu, Wenhua Li, Jing Yu and Dao Wen Wang. Their work appears in journals such as Clinical Cardiology, Shock, Biochemical Pharmacology, Aging Cell and Pharmacological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.